Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment

References

• Haymaker WE, Kernohan JW. The Landry-Guillain-Barré syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore). 1949;28:59–141.
   PubMed Web of Science ®Google Scholar
• Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain. 1986;109:1115–1126.
   PubMed Web of Science ®Google Scholar
• Sheikh KA, Nachamkin I, Ho TW, et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome: molecular mimicry and host susceptibility. Neurology. 1998;51:371–378.
   PubMed Web of Science ®Google Scholar
• Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst. 2005;10:94–112.
   PubMed Web of Science ®Google Scholar
• Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A. 2004;101:11404–11409.
   PubMed Web of Science ®Google Scholar
• Yuki N, Hartung H-P. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294–2304.
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Swan AV, Raphaël J-C, et al. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130:2245–2257.
   PubMed Web of Science ®Google Scholar
• Aharoni R. Immunomodulation neuroprotection and remyelination – the fundamental therapeutic effects of glatiramer acetate: a critical review. J Autoimmun. 2014;54:81–92.
   PubMed Web of Science ®Google Scholar
• Schwartz M, Baruch K. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation. J Autoimmun. 2014;54:8–14.
   PubMed Web of Science ®Google Scholar
• Ben-Nun A, Kaushansky N, Kawakami N, et al. From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development. J Autoimmun. 2014;54:33–50.
   PubMed Web of Science ®Google Scholar
• Hollenbach JA, Oksenberg JR. The immunogenetics of multiple sclerosis: a comprehensive review. J Autoimmun. 2015;64:13–25.
   PubMed Web of Science ®Google Scholar
• Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134–142.
   PubMed Web of Science ®Google Scholar
• Steinman L, Shoenfeld Y. From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela. J Autoimmun. 2014;54:1–7.
   PubMed Web of Science ®Google Scholar
• Saariaho A-H, Vuorela A, Freitag TL, et al. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J Autoimmun. 2015;63:68–75.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun S, Zhu J, et al. Biomarkers of Guillain-Barre syndrome: some recent progress, more still to be explored. Mediators Inflamm. 2015;2015:564098.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Baughman AL, Wise M, et al. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–133.
   PubMed Web of Science ®Google Scholar
• Islam Z, Jacobs BC, Islam MB, et al. High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg Infect Dis. 2011;17:1317–1318.
   PubMed Web of Science ®Google Scholar
• Rocha MSG, Brucki SMD, Carvalho AADS, et al. Epidemiologic features of Guillain-Barré syndrome in São Paulo, Brazil. Arq Neuropsiquiatr. 2004;62:33–37.
   PubMed Web of Science ®Google Scholar
• Zhang G, Li Q, Zhang R, et al. Subtypes and prognosis of Guillain-Barré syndrome in Southwest China. PLoS One. 2015;10:e0133520.
   PubMed Web of Science ®Google Scholar
• Nachamkin I, Arzarte Barbosa P, Ung H, et al. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology. 2007;69:1665–1671.
   PubMed Web of Science ®Google Scholar
• Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998;44:780–788.
   PubMed Web of Science ®Google Scholar
• Islam Z, Jacobs BC, van Belkum A, et al. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology. 2010;74:581–587.
   PubMed Web of Science ®Google Scholar
• Deceuninck G, Boucher R-M, De Wals P, et al. Epidemiology of Guillain-Barré syndrome in the province of Quebec. Can J Neurol Sci. 2008;35:472–475.
   PubMed Web of Science ®Google Scholar
• Winner SJ, Evans JG. Age-specific incidence of Guillain-Barré syndrome in Oxfordshire. Q J Med. 1990;77:1297–1304.
   PubMedGoogle Scholar
• Govoni V, Granieri E, Manconi M, et al. Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J Neurol Sci. 2003;216:99–103.
   PubMed Web of Science ®Google Scholar
• Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110:100–106.
   PubMed Web of Science ®Google Scholar
• Chiò A, Cocito D, Leone M, et al. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology. 2003;60:1146–1150.
   PubMed Web of Science ®Google Scholar
• Sedano MJ, Calleja J, Canga E, et al. Guillain-Barre syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand. 1994;89:287–292.
   PubMed Web of Science ®Google Scholar
• Aladro-Benito Y, Conde-Sendin MA, Munoz-Fernandez C, et al. Guillain-Barre syndrome in the northern area of Gran Canaria and the island of Lanzarote. Rev Neurol. 2002;35:705–710.
   PubMed Web of Science ®Google Scholar
• Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Guillain-Barre syndrome in Spain, 1985–1997: epidemiological and public health views. Eur Neurol. 2001;46:83–91.
   PubMed Web of Science ®Google Scholar
• Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurol Sci. 2004;25:57–65.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Jiang GX, Fredrikson S, et al. Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol. 2000;7:11–16.
   PubMed Web of Science ®Google Scholar
• Beghi E, Kurland LT, Mulder DW, et al. Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol. 1985;42:1053–1057.
   PubMedGoogle Scholar
• Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am J Epidemiol. 1979;110:105–123.
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis. 1997;176(s2):SS92–SS98.
   PubMed Web of Science ®Google Scholar
• Tam CC, Rodrigues LC, Petersen I, et al. Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis. 2006;194:95–97.
   PubMed Web of Science ®Google Scholar
• Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51:1110–1115.
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Yuki N. Infectious and noninfectious triggers in Guillain-Barre syndrome. Expert Rev Clin Immunol. 2013;9:627–639.
   PubMed Web of Science ®Google Scholar
• Hadden RD, Karch H, Hartung HP, et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology. 2001;56:758–765.
   PubMed Web of Science ®Google Scholar
• Williams CJ, Thomas RH, Pickersgill TP, et al. Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016. Euro Surveill. 2016;21(4).
   PubMedGoogle Scholar
• Smith DW, Mackenzie J. Zika virus and Guillain-Barré syndrome: another viral cause to add to the list. Lancet. 2016;387:1486–1488. pii: S0140-6736(16)00564-X
   PubMed Web of Science ®Google Scholar
• Gervaix A, Caflisch M, Suter S, et al. Guillain-Barré syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine. Eur J Pediatr. 1993;152:613–614.
   PubMed Web of Science ®Google Scholar
• Israeli E, Agmon-Levin N, Blank M, et al. Guillain-Barre syndrome – a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol. 2012;42:121–130.
   PubMed Web of Science ®Google Scholar
• Gilbert M, Karwaski M-F, Bernatchez S, et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 2002;277:327–337.
   PubMed Web of Science ®Google Scholar
• Kokubun N, Shahrizaila N, Hirata K, et al. Conduction block and axonal degeneration co-occurring in a patient with axonal Guillain-Barré syndrome. J Neurol Sci. 2012;319:164–167.
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Ogawara K, Misawa S, et al. Does Campylobacter jejuni infection elicit ‘demyelinating’ Guillain-Barre syndrome? Neurology. 2004;63:529–533.
   PubMed Web of Science ®Google Scholar
• Drenthen J, Yuki N, Meulstee J, et al. Guillain-Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry. 2011;82:300–305.
   PubMed Web of Science ®Google Scholar
• Yuki N, Yoshino H, Sato S, et al. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 1990;40:1900–1902.
   PubMed Web of Science ®Google Scholar
• Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol. 1999;45:168–173.
   PubMed Web of Science ®Google Scholar
• Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993;178:1771–1775.
   PubMed Web of Science ®Google Scholar
• van den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–482.
   PubMed Web of Science ®Google Scholar
• Nyati KK, Nyati R. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barre syndrome: an update. Biomed Res Int. 2013;2013:852195.
   PubMed Web of Science ®Google Scholar
• Sharma MB, Chaudhry R, Tabassum I, et al. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome. J Infect Dev Ctries. 2011;5:459–464.
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology. 2001;57:736–738.
   PubMed Web of Science ®Google Scholar
• Yuki N, Taki T, Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barre syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol. 1996;71:155–161.
   PubMed Web of Science ®Google Scholar
• Susuki K, Odaka M, Mori M, et al. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology. 2004;62:949–956.
   PubMed Web of Science ®Google Scholar
• Winer JB. An update in Guillain-Barré syndrome. Autoimmune Dis. 2014;2014:793024.
   PubMedGoogle Scholar
• Houliston RS, Koga M, Li J, et al. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry. 2007;46:8164–8171.
   PubMed Web of Science ®Google Scholar
• Miller B, Kassenborg H, Dunsmuir W, et al. Syndromic surveillance for influenzalike illness in ambulatory care setting. Emerg Infect Dis. 2004;10:1806–1811.
   PubMed Web of Science ®Google Scholar
• Koga M, Koike S, Hirata K, et al. Ambiguous value of Haemophilus influenzae isolation in Guillain-Barre and Fisher syndromes. J Neurol Neurosurg Psychiatry. 2005;76:1736–1738.
   PubMed Web of Science ®Google Scholar
• Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol. 1996;16:105–115.
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Miyake M, et al. Haemophilus influenzae infection and Guillain-Barré syndrome. Brain. 2000;123:2171–2178.
   PubMed Web of Science ®Google Scholar
• Nahata MC. Ophthalmoplegia following enteric fever. J Indian Med Assoc. 1961;37:134–135.
   PubMedGoogle Scholar
• Nager F, Regli F. Polyneuritis with flaccid tetraplegia in typhoid fever. Schweiz Med Wochenschr. 1963;93:1030–1033.
   PubMedGoogle Scholar
• Samantray SK, Johnson SC, Mathai KV, et al. Landry-Guillain-Barré-Strohl syndrome. A study of 302 cases. Med J Aust. 1977;2:84–91.
   PubMed Web of Science ®Google Scholar
• Osuntokun BO, Bademosi O, Ogunremi K, et al. Neuropsychiatric manifestations of typhoid fever in 959 patients. Arch Neurol. 1972;27:7–13.
   PubMedGoogle Scholar
• Khan FY, Kamha AA, Abbas MT, et al. Guillain-Barré syndrome associated with Salmonella paratyphi A. Clin Neurol Neurosurg. 2007;109:452–454.
   PubMed Web of Science ®Google Scholar
• Nafissi S, Vahabi Z, Sadeghi Ghahar M, et al. The role of cytomegalovirus, Haemophilus influenzae and Epstein Barr virus in Guillain Barre syndrome. Acta Med Iran. 2013;51:372–376.
   PubMedGoogle Scholar
• Orlikowski D, Porcher R, Sivadon-Tardy V, et al. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis. 2011;52:837–844.
   PubMed Web of Science ®Google Scholar
• Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016. S0140-6736(16)00339-1.
   Web of Science ®Google Scholar
• Klemola E, Weckman N, Haltia K, et al. The Guillain-Barré syndrome associated with acquired cytomegalovirus infection. Acta Med Scand. 1967;181:603–607.
   PubMedGoogle Scholar
• Yuki N, Tagawa Y. Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci. 1998;154:14–17.
   PubMed Web of Science ®Google Scholar
• Alhefzi M, Aycart MA, Bueno EM, et al. Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation. Transpl Infect Dis. 2016;18:288–292.
   PubMed Web of Science ®Google Scholar
• Spagnoli C, Iodice A, Salerno GG, et al. CMV-associated axonal sensory-motor Guillain-Barre syndrome in a child: case report and review of the literature. Eur J Paediatr Neurol. 2016;20:168–175.
   PubMed Web of Science ®Google Scholar
• Taheraghdam A, Pourkhanjar P, Talebi M, et al. Correlations between cytomegalovirus, Epstein-Barr virus, anti-ganglioside antibodies, electrodiagnostic findings and functional status in Guillain-Barre syndrome. Iran J Neurol. 2014;13:7–12.
   PubMedGoogle Scholar
• Kennedy M, Apostolova M. A rare case of infectious mononucleosis complicated by Guillain-Barre syndrome. Neurol Int. 2013;5:20–22.
   PubMedGoogle Scholar
• Rho Y II. Overlapping Guillain-Barre syndrome and Bickerstaff’s brainstem encephalitis associated with Epstein Barr virus. Korean J Pediatr. 2014;57:457–460.
   PubMedGoogle Scholar
• Bitan M, Or R, Shapira MY, et al. Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin Infect Dis. 2004;39:1076–1078.
   PubMed Web of Science ®Google Scholar
• Kim SY, Choe K-W, Park S, et al. Mild form of Guillain-Barre syndrome in a patient with primary Epstein-Barr virus infection. Korean J Intern Med. 2016.
   Google Scholar
• Kang J-H, Sheu J-J, Lin H-C. Increased risk of Guillain-Barré Syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis. 2010;51:525–530.
   PubMed Web of Science ®Google Scholar
• Tatarelli P, Garnero M, Del Bono V, et al. Guillain-Barre syndrome following chickenpox: a case series. Int J Neurosci. 2016;126:478–479.
   PubMed Web of Science ®Google Scholar
• Tam CC, O’Brien SJ, Petersen I, et al. Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One. 2007;2:e344.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009;169:382–388.
   PubMed Web of Science ®Google Scholar
• Sivadon-Tardy V, Orlikowski D, Porcher R, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2009;48:48–56.
   PubMed Web of Science ®Google Scholar
• Cortese A, Baldanti F, Tavazzi E, et al. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature. J Neurol Sci. 2012;312:173–176.
   PubMed Web of Science ®Google Scholar
• Kutlesa M, Santini M, Krajinović V, et al. Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocrit Care. 2010;13:98–100.
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Alpérovitch A, Besson G, et al. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol. 2011;174:326–335.
   PubMed Web of Science ®Google Scholar
• Simpson BS, Rajabally YA. Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection. Eur J Neurol. 2009;16:e81.
   PubMedGoogle Scholar
• Yuki N, Takahashi Y, Ihara T, et al. Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination. J Neurol Neurosurg Psychiatry. 2012;83:116–117.
   PubMed Web of Science ®Google Scholar
• Beadling C, Slifka MK. How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis. 2004;17:185–191.
   PubMed Web of Science ®Google Scholar
• Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014;58:1149–1155.
   PubMed Web of Science ®Google Scholar
• Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987;21:32–40.
   PubMed Web of Science ®Google Scholar
• Wagner JC, Bromberg MB. HIV infection presenting with motor axonal variant of Guillain-Barré syndrome. J Clin Neuromuscul Dis. 2007;9:303–305.
   PubMedGoogle Scholar
• Hiraga A, Kuwabara S, Nakamura A, et al. Fisher/Gullain-Barré overlap syndrome in advanced AIDS. J Neurol Sci. 2007;258:148–150.
   PubMed Web of Science ®Google Scholar
• Berger JR, Difini JA, Swerdloff MA, et al. HIV seropositivity in Guillain-Barré syndrome. Ann Neurol. 1987;22:393–394.
   PubMed Web of Science ®Google Scholar
• Piette AM, Tusseau F, Vignon D, et al. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet. 1986;327:852.
   Google Scholar
• Parry O, Mielke J, Latif AS, et al. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol Scand. 1997;96:218–222.
   PubMed Web of Science ®Google Scholar
• Piliero PJ, Fish DG, Preston S, et al. Guillain-Barré syndrome associated with immune reconstitution. Clin Infect Dis. 2003;36:e111–4.
   Web of Science ®Google Scholar
• Brannagan TH, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003;208:39–42.
   PubMed Web of Science ®Google Scholar
• Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr. 1991;4:598–602.
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Pezeshkpour GH. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol. 1988;23(S1):SS38–SS48.
   Google Scholar
• Souayah N, Mian NF, Gu Y, et al. Elevated anti-sulfatide antibodies in Guillain-Barré syndrome in T cell depleted at end-stage AIDS. J Neuroimmunol. 2007;188:143–145.
   PubMed Web of Science ®Google Scholar
• Garcia-Rivera EJ, Vorndam V, Rigau-Perez JG, et al. Use of an enhanced surveillance system for encephalitis and aseptic meningitis for the detection of neurologic manifestations of dengue in Puerto Rico, 2003. P R Health Sci J. 2009;28:114–120.
   PubMed Web of Science ®Google Scholar
• Kumar S, Prabhakar S. Guillain-Barre syndrome occurring in the course of dengue fever. Neurol India. 2005;53:250–251.
   PubMedGoogle Scholar
• Sulekha C, Kumar S, Philip J. Guillain-Barre syndrome following dengue fever. Indian Pediatr. 2004;41:948–950.
   PubMedGoogle Scholar
• Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, et al. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology. 2009;73:1413–1417.
   PubMed Web of Science ®Google Scholar
• Palma-da Cunha-Matta A, Soares-Moreno SA, Cardoso-de Almeida A, et al. Neurological complications arising from dengue virus infection. Rev Neurol. 2004;39:233–237.
   PubMed Web of Science ®Google Scholar
• Oehler E, Le Henaff O, Larre P, et al. Guillain-Barré syndrome following type 4 dengue in Polynesia. Méd Trop (Mars). 2011;71:203–204.
   PubMedGoogle Scholar
• Gonçalves E. Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) following dengue fever. Rev Do Inst Med Trop São Paulo. 2011;53:223–225.
   PubMed Web of Science ®Google Scholar
• Jackson ST, Mullings A, Bennett F, et al. Dengue infection in patients presenting with neurological manifestations in a dengue endemic population. West Indian Med J. 2008;57:373–376.
   PubMed Web of Science ®Google Scholar
• Chen T-Y, Lee C-T. Guillain-Barré syndrome following dengue fever. Ann Emerg Med. 2007;50:94–95.
   PubMed Web of Science ®Google Scholar
• Santos NQ, Azoubel ACB, Lopes AA, et al. Guillain-Barré syndrome in the course of dengue: case report. Arq Neuropsiquiatr. 2004;62:144–146.
   PubMed Web of Science ®Google Scholar
• Esack A, Teelucksingh S, Singh N. The Guillain-Barré syndrome following dengue fever. West Indian Med J. 1999;48:36–37.
   PubMed Web of Science ®Google Scholar
• Soares CN, Cabral-Castro M, Oliveira C, et al. Oligosymptomatic dengue infection: a potential cause of Guillain Barré syndrome. Arq Neuropsiquiatr. 2008;66:234–237.
   PubMed Web of Science ®Google Scholar
• Chaudhary SC, Mohanty D, Sonkar SK, et al. Unusual manifestation of dengue fever. BMJ Case Rep. 2011 Jun 29;2011.
   Google Scholar
• Hira HS, Kaur A, Shukla A. Acute neuromuscular weakness associated with dengue infection. J Neurosci Rural Pract. 2012;3:36–39.
   PubMedGoogle Scholar
• Verma R, Sahu R, Holla V. Neurological manifestations of dengue infection: a review. J Neurol Sci. 2014;346:26–34.
   PubMed Web of Science ®Google Scholar
• Ralapanawa DMP, Kularatne SAM, Jayalath WATA. Guillain-Barre syndrome following dengue fever and literature review. BMC Res Notes. 2015;8:729.
   PubMedGoogle Scholar
• Oehler E, Fournier E, Leparc-Goffart I, et al. Increase in cases of Guillain-Barré syndrome during a chikungunya outbreak, French Polynesia, 2014 to 2015. Euro Surveill. 2015;20(48):30079.
   PubMedGoogle Scholar
• Villamil-Gómez W, Silvera LA, Páez-Castellanos J, et al. Guillain-Barré syndrome after chikungunya infection: A case in Colombia. Enfermedades Infecc Y Microbiol Clínica. 2016;34:140–141.
   PubMed Web of Science ®Google Scholar
• Jaffar-Bandjee MC, Ramful D, Gauzere BA, et al. Emergence and clinical insights into the pathology of chikungunya virus infection. Expert Rev Anti Infect Ther. 2010;8:987–996.
   PubMed Web of Science ®Google Scholar
• Lebrun G, Chadda K, Reboux A-H, et al. Guillain-Barré syndrome after chikungunya infection. Emerg Infect Dis. 2009;15:495–496.
   PubMed Web of Science ®Google Scholar
• Tournebize P, Charlin C, Lagrange M. Neurological manifestations in chikungunya: about 23 cases collected in Reunion Island. Rev Neurol. 2009;165:48–51.
   PubMed Web of Science ®Google Scholar
• Lemant J, Boisson V, Winer A, et al. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006. Crit Care Med. 2008;36:2536–2541.
   PubMed Web of Science ®Google Scholar
• Wielanek AC, De Monredon J, El Amrani M, et al. Guillain-Barré syndrome complicating a chikungunya virus infection. Neurology. 2007;69:2105–2107.
   PubMed Web of Science ®Google Scholar
• Economopoulou A, Dominguez M, Helynck B, et al. Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion. Epidemiol Infect. 2009;137:534–541.
   PubMed Web of Science ®Google Scholar
• Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barre syndrome – case report, French Polynesia, December 2013. Euro Surveill. 2014;19:9.
   Google Scholar
• Anaya J-M, Ramirez-Santana C, Salgado-Castaneda I, et al. Zika virus and neurologic autoimmunity: the putative role of gangliosides. BMC Med. 2016;14:49.
   PubMed Web of Science ®Google Scholar
• Weaver SC, Costa F, Garcia-Blanco MA, et al. Zika virus: history, emergence, biology, and prospects for control. Antiviral Res. 2016;130:69–80.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, O’Connor C, Kirkbride H, et al. Outbreak of Zika virus disease in the Americas and the association with microcephaly, congenital malformations and Guillain-Barré syndrome. Arch Dis Child. 2016 Mar 14.
   Web of Science ®Google Scholar
• Malkki H. CNS infections: Zika virus infection could trigger Guillain-Barré syndrome. Nat Rev Neurol. 2016;12:187.
   Google Scholar
• Carod-Artal FJ. Epidemiology and neurological complications of infection by the Zika virus: a new emerging neurotropic virus. Rev Neurol. 2016;62:317–328.
   PubMed Web of Science ®Google Scholar
• Roze B, Najioullah F, Ferge J-L, et al. Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016. Euro Surveill. 2016;21(9).
   Google Scholar
• Cao-Lormeau V-M, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531–1539.
   PubMed Web of Science ®Google Scholar
• Wise J. Study links Zika virus to Guillain-Barré syndrome. BMJ. 2016;352:i1242.
   Google Scholar
• Chang C, Ortiz K, Ansari A, et al. The Zika outbreak of the 21st century. J Autoimmun. 2016;68:1–13.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Sharp TM, Torres J, et al. Local transmission of Zika virus – Puerto Rico, November 23, 2015-January 28, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(6):154–158.
   PubMed Web of Science ®Google Scholar
• Pinto Junior VL, Luz K, Parreira R, et al. Zika virus: a review to clinicians. Acta Médica Port. 2015;28:760–765.
   PubMed Web of Science ®Google Scholar
• Gatherer D, Kohl A. Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol. 2016;97:269–273.
   PubMed Web of Science ®Google Scholar
• Ayres CFJ. Identification of Zika virus vectors and implications for control. Lancet Infect Dis. 2016;16:278–279.
   PubMed Web of Science ®Google Scholar
• Ioos S, Mallet H-P, Leparc Goffart I, et al. Current Zika virus epidemiology and recent epidemics. Médecine Mal Infect. 2014;44:302–307.
   PubMed Web of Science ®Google Scholar
• Lucey DR. Time for global action on Zika virus epidemic. BMJ. 2016;352:i781.
   Google Scholar
• Ang CW, Jacobs BC, Laman JD. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol. 2004;25:61–66.
   PubMed Web of Science ®Google Scholar
• Shahrizaila N, Yuki N. Guillain-Barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol. 2011;2011:829129.
   PubMedGoogle Scholar
• Anaya J, Shoenfeld Y, Rojas-Villarraga A, et al. Autoimmunity. From bench to bedside. Bogotá: El Rosario University Press; 2013.
   Google Scholar
• Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore). 1969;48:173–215.
   PubMed Web of Science ®Google Scholar
• Prineas JW. Pathology of the Guillain-Barré syndrome. Ann Neurol. 1981;9(S1):6–19.
   PubMed Web of Science ®Google Scholar
• Pritchard J, Makowska A, Gregson NA, et al. Reduced circulating CD4+CD25+ cell populations in Guillain-Barré syndrome. J Neuroimmunol. 2007;183:232–238.
   PubMed Web of Science ®Google Scholar
• Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996;40:635–644.
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653–1666.
   PubMed Web of Science ®Google Scholar
• Berciano J, García A, Figols J, et al. Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy. Neurology. 2000;55:552–559.
   PubMed Web of Science ®Google Scholar
• Nyati KK, Prasad KN, Rizwan A, et al. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome. Arch Neurol. 2011;68:445–452.
   PubMed Web of Science ®Google Scholar
• Li S, Jin T, Zhang H-L, et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm. 2014;2014:740947.
   PubMed Web of Science ®Google Scholar
• Gong Y, Tagawa Y, Lunn MPT, et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain. 2002;125:2491–2506.
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Kokubun N, Misawa S, et al. Neuromuscular transmission is not impaired in axonal Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry. 2011;82:1174–1177.
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–1917.
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve. 1999;22:1071–1074.
   PubMed Web of Science ®Google Scholar
• Liu J-X, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci. 2009;50:3226–3232.
   PubMed Web of Science ®Google Scholar
• Kaida K, Morita D, Kanzaki M, et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol. 2004;56:567–571.
   PubMed Web of Science ®Google Scholar
• Ito M, Kuwabara S, Odaka M, et al. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008;255:674–682.
   PubMed Web of Science ®Google Scholar
• Nagashima T, Koga M, Odaka M, et al. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. Arch Neurol. 2007;64:1519–1523.
   PubMed Web of Science ®Google Scholar
• Yuki N, Yamada M, Koga M, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 2001;49:712–720.
   PubMed Web of Science ®Google Scholar
• Uncini A, Yuki N. Sensory Guillain-Barré syndrome and related disorders: an attempt at systematization. Muscle Nerve. 2012;45:464–470.
   PubMed Web of Science ®Google Scholar
• Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry. 2013;84:98–106.
   PubMed Web of Science ®Google Scholar
• Yuki N, Kokubun N, Kuwabara S, et al. Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol. 2012;259:1181–1190.
   PubMed Web of Science ®Google Scholar
• Hiraga A, Mori M, Ogawara K, et al. Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes. Neurology. 2003;61:471–474.
   PubMed Web of Science ®Google Scholar
• Asahina M, Kuwabara S, Suzuki A, et al. Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome. Acta Neurol Scand. 2002;105:44–50.
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013;12:1180–1188.
   PubMed Web of Science ®Google Scholar
• Kanda T, Hayashi H, Tanabe H, et al. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry. 1989;52:857–864.
   PubMed Web of Science ®Google Scholar
• Berciano J, Coria F, Montón F, et al. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination. Muscle Nerve. 1993;16:744–751.
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104–1106.
   PubMed Web of Science ®Google Scholar
• Koga M, Yoshino H, Morimatsu M, et al. Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2002;72:767–771.
   PubMed Web of Science ®Google Scholar
• Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol. 1981;9(S1):1–5.
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27(S1):SS21–SS24.
   Google Scholar
• Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barré and Miller Fisher syndromes – new diagnostic classification. Nat Rev Neurol. 2014;10:537–544.
   PubMed Web of Science ®Google Scholar
• Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137:33–43.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599–612.
   PubMed Web of Science ®Google Scholar
• Wong AHY, Umapathi T, Nishimoto Y, et al. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst. 2015;20:47–51.
   Web of Science ®Google Scholar
• Kurt Incesu T, Secil Y, Tokucoglu F, et al. Diagnostic value of lumbar root stimulation at the early stage of Guillain-Barré syndrome. Clin Neurophysiol. 2013;124:197–203.
   PubMed Web of Science ®Google Scholar
• Gallardo E, Sedano MJ, Orizaola P, et al. Spinal nerve involvement in early Guillain-Barré syndrome: a clinico-electrophysiological, ultrasonographic and pathological study. Clin Neurophysiol. 2015;126:810–819.
   PubMed Web of Science ®Google Scholar
• Grimm A, Décard BF, Schramm A, et al. Ultrasound and electrophysiologic findings in patients with Guillain-Barré syndrome at disease onset and over a period of six months. Clin Neurophysiol. 2016;127:1657–1663.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Servidei S, Modoni A, et al. Admission neurophysiological abnormalities in Guillain-Barré syndrome: A single-center experience. Clin Neurol Neurosurg. 2015;135:6–10.
   PubMed Web of Science ®Google Scholar
• Derksen A, Ritter C, Athar P, et al. Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics. Muscle Nerve. 2014;50:780–784.
   PubMed Web of Science ®Google Scholar
• Van den Bergh PYK, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004;29:565–574.
   PubMed Web of Science ®Google Scholar
• Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123:1487–1495.
   PubMed Web of Science ®Google Scholar
• Mori K, Hattori N, Sugiura M, et al. Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology. 2002;58:979–982.
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barre and Miller Fisher syndromes. Pract Neurol. 2015;15:90–99. doi:10.1136/practneurol-2014-000937.
   PubMedGoogle Scholar
• Koike H, Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol. 2003;54:19–29.
   PubMed Web of Science ®Google Scholar
• Chalela JA. Pearls and pitfalls in the intensive care management of Guillain-Barré syndrome. Semin Neurol. 2001;21:399–406.
   PubMed Web of Science ®Google Scholar
• Polkey MI, Lyall RA, Moxham J, et al. Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry. 1999;66:5–15.
   PubMed Web of Science ®Google Scholar
• Zhang G, Lehmann HC, Bogdanova N, et al. Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy. PLoS One. 2011;6:e27067.
   PubMed Web of Science ®Google Scholar
• Zhang G, Lehmann HC, Manoharan S, et al. Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth. J Neurosci. 2011;31:1664–1675.
   PubMed Web of Science ®Google Scholar
• The Guillain-Barré syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology. 1985;35:1096–1104.
   PubMed Web of Science ®Google Scholar
• The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré syndrome. Ann Neurol. 1997;41:298–306.
   PubMed Web of Science ®Google Scholar
• van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med. 1992;326:1123–1129.
   PubMed Web of Science ®Google Scholar
• Jacobs BC, O’Hanlon GM, Bullens RWM, et al. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain. 2003;126:2220–2234.
   PubMed Web of Science ®Google Scholar
• Kuitwaard K, de Gelder J, Tio-Gillen AP, et al. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol. 2009;66:597–603.
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Fukutake T, et al. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology. 2007;68:1144–1146.
   PubMed Web of Science ®Google Scholar
• van Koningsveld R, Schmitz PIM, Meché FGA, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet. 2004;363:192–196.
   PubMed Web of Science ®Google Scholar
• Vega D, Peña M, Lorenzana P. Sindrome de Guillain-Barré (SGB). Acta Colomb Cuid Intensivo. 2008;8:219–228.
   Google Scholar
• Netto AB, Taly AB, Kulkarni GB, et al. Mortality in mechanically ventilated patients of Guillain Barré Syndrome. Ann Indian Acad Neurol. 2011;14:262–266.
   PubMed Web of Science ®Google Scholar
• Selmi C, Meroni PL, Gershwin ME. Primary biliary cirrhosis and Sjögren’s syndrome: autoimmune epithelitis. J Autoimmun. 2012;39:34–42.
   PubMed Web of Science ®Google Scholar
• Miller FW, Pollard KM, Parks CG, et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012;39:253–258.
   PubMed Web of Science ®Google Scholar
• Selmi C, Leung PSC, Sherr DH, et al. Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun. 2012;39:272–284.
   PubMed Web of Science ®Google Scholar
• Selmi C, Gershwin ME. The role of environmental factors in primary biliary cirrhosis. Trends Immunol. 2009;30:415–420.
   PubMed Web of Science ®Google Scholar
• D’Amico F, Skarmoutsou E, Mazzarino MC. The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance. Clin Rev Allergy Immunol. 2014;47:334–343.
   PubMed Web of Science ®Google Scholar
• Saito Y, Saito H, Liang G, et al. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol. 2014;47:128–135.
   PubMed Web of Science ®Google Scholar
• Selmi C, Lu Q, Humble MC. Heritability versus the role of the environment in autoimmunity. J Autoimmun. 2012;39:249–252.
   PubMed Web of Science ®Google Scholar
• Adutler-Lieber S, Zaretsky I, Platzman I, et al. Engineering of synthetic cellular microenvironments: implications for immunity. J Autoimmun. 2014;54:100–111.
   PubMed Web of Science ®Google Scholar
• Jenkinson WE, McCarthy NI, Dutton EE, et al. Natural Th17 cells are critically regulated by functional medullary thymic microenvironments. J Autoimmun. 2015;63:13–22.
   PubMed Web of Science ®Google Scholar
• Tsuda M, Torgerson TR, Selmi C, et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun. 2010;35:265–268.
   PubMed Web of Science ®Google Scholar
• Bogdanos DP, Smyk DS, Rigopoulou EI, et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 2012;38:J156–69.
   PubMed Web of Science ®Google Scholar
• Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol. 2008;22:913–922.
   PubMed Web of Science ®Google Scholar
• Selmi C, Feghali-Bostwick CA, Lleo A, et al. X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma. Clin Exp Immunol. 2012;169:253–262.
   PubMed Web of Science ®Google Scholar
• Mitchell MM, Lleo A, Zammataro L, et al. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics. 2011;6:95–102.
   PubMed Web of Science ®Google Scholar
• Rogatsky I, Chandrasekaran U, Manni M, et al. Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity. Autoimmunity. 2014;47:242–255.
   PubMed Web of Science ®Google Scholar
• Zan H. Epigenetics in lupus. Autoimmunity. 2014;47:213–214.
   PubMed Web of Science ®Google Scholar
• Meda F, Folci M, Baccarelli A, et al. The epigenetics of autoimmunity. Cell Mol Immunol. 2011;8:226–236.
   PubMed Web of Science ®Google Scholar
• Lu Q, Renaudineau Y, Cha S, et al. Epigenetics in autoimmune disorders: highlights of the 10th Sjögren’s syndrome symposium. Autoimmun Rev. 2010;9:627–630.
   PubMed Web of Science ®Google Scholar